LLY | Eli Lilly & Co.NYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$1,409
-$1.61 (-0.11%)

Eli Lilly & Co. (LLY) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $1,409 vs 50 $1,204 / 200 $1,095
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 Nov 2025 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $1,418 vs 50 $1,089 / 200 $787.21
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
above both $1,422 vs 50 $1,245 / 200 $1,192
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 Oct 2026 ยท projected 14 bars out

Cross history

20
crosses on record since 2018
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Oct 2026Golden4-hour14 bars outNot tested
6 Oct 2026Death4-hour17 bars out2 bar cross test
1 Jun 2026Golden4-hour24 bars outNot tested
17 Mar 2026Death4-hour30 bars outNot tested
5 Nov 2025Golden steepdaily26 bars outNot tested

About LLY

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$2.7B
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmega

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.